# Enoxaparin Sodium

NDC: 68001-464
Generic name: enoxaparin sodium
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20201019

FDA application: ANDA208600

## Active ingredients

- ENOXAPARIN SODIUM: 300 mg/3mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-464"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-464
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e2875df-0f0c-46ec-990f-69108f383f58